IDIrina S. Dydykina

Irina S. Dydykina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Irina S. Dydykina has a total of 96 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Radiographic progression and changes in bone mineral density in patients with rheumatoid arthritis during long-term follow-up

    by P. S. Kovalenko, I. S. Dydykina, A. V. Smirnov, S. I. Glukhova, E. L. Nasonov, П. С. Коваленко, И. С. Дыдыкина, А. В. Смирнов, С. И. Глухова, Е. Л. Насонов

    Introduction . Joint inflammation in rheumatoid arthritis (RA) is accompanied by erosive and destructive changes, decreased bone mineral density (BMD), and impaired joint function. Aim . To study the rate of radiographic progression (RP) in patients with RA, taking into account BMD, comorbidities, and anti-inflammatory therapy during long-term follow-up. Materials and methods . A prospective, multi-year cohort study involving 151 women with RA, aged 53.9 ± 9.2 years. Followup was 9.7 ± 1.7 years. A dynamic clinical, laboratory, and radiographic examination was performed, analyzing changes in the Steinbrocker RA stage, Sharp erosion score, BMD at L1-L4, and in the proximal femur (PF). Results . Slow RP (SRP) was detected in 63 (42%) patients, and rapid RP (RP) – in 32 (21%) patients. The age of patients with SRP was younger, including at the onset of RA, the duration of RA and the Sharp score were higher, the MIC in the POB and the methotrexate dose were lower. DAS28, positivity and levels of RF, anti-CCP, CRP, MIC L1-L4 in the SRP and SRP groups were comparable. Patients with SRP more often received glucocorticoids (GC), the duration of therapy, daily and cumulative dose of GC were higher (p < 0.0001). In the SRP group, the number of patients with coronary artery disease, chronic heart failure, and chronic kidney disease increased. The incidence of fractures in the MRP group increased from 17.4% to 47.6% (p < 0.001) versus 31.2% to 56.2% (p < 0.04) in the BRP group. The incidence of osteoporosis remained unchanged between the groups. Total joint replacement (TJR) was required in 34.3% of patients with MRP versus 7.9% with MRP (p = 0.006). Conclusions. TJR was detected in patients with RA duration of more than 5 years receiving GC therapy; it is associated with decreased BMD, fractures, decreased quality of life, and the need for total joint replacement.

  • Rate of radiographic progression of rheumatoid arthritis. Results of long-term observation

    by P. S. Kovalenko, I. S. Dydykina, A. V. Smirnov, A. S. Avdeeva, S. I. Glukhova, E. L. Nasonov

    Introduction. Radiographic progression (RP) of rheumatoid arthritis (RA) is one of the main signs of the disease and a key factor in assessing the effectiveness of therapy. RP is accompanied by an increase in the number of erosions, narrowed joint spaces, and radiographic stage (Rg stage). The aim – to compare the characteristics of patients with rheumatoid arthritis with rapid and slow rates of radiographic progression during long-term follow-up. Materials and methods . A prospective cohort study lasting 9.7±1.7 years included 151 women with RA aged 53.9±9.2 years. All patients underwent clinical, laboratory, and radiographic examinations. RP was analyzed taking into account changes in the Steinbrocker RA stage, the number of erosions, and the degree of joint space narrowing using the Sharp/van der Heijde (SVH) method. Results . An increase in the erosion count according to SVH was detected in 66 (53%) patients, and narrowed clefts – in 81 (65%) patients. The number of patients with Rg1, Rg2, and Rg3 decreased; those with Rg4 increased from 29 (19%) to 54 (36%) people (pConclusions. A long-term prospective study demonstrated RP despite achieving remission and decreasing activity in the majority of RA patients. The rate of RP depends on many factors, both RA-related and non-RA-related. Distinguishing phenotypes of RA patients with rapid and slow RP will enable a personalized approach to patient management.

  • Open Access

    Bioactive concentrate from small marine fish: The path from safety and efficacy analysis to clinical recommendations

    by I. S. Dydykina, P. S. Kovalenko, A. A. Kovalenko

    A comprehensive, multimodal, patient-centered approach to the treatment of osteoarthritis (OA) using non-pharmacological and pharmacological treatments can significantly improve the disease course and outcomes. Pathogenetically based introduction of new drugs and medications into therapy, as well as expanded indications for well-studied and safe medications, allow for an expanded arsenal of medications for the treatment of OA. Extensive experience has been accumulated over more than 30 years using preparations containing bioactive small marine fish concentrate (SMFC). In the Russian Register of Medicines (RLS), injectable SMFCs are included in the clinical-pharmacological group of tissue reparation stimulators of natural origin and are classified as “bone and cartilage metabolism correctors” or “other drugs for the treatment of musculoskeletal diseases”. SMFCs are intended to reduce pain and achieve a structure-modifying effect with long-term use. Intramuscular and intraarticular administration of CMMRs increase bioavailability, reduce the frequency of drug administration, and ensure a rapid onset of effect. Thanks to the high-quality evidence accumulated during clinical trials investigating the safety and efficacy of CMMRs for knee, hip, and small joint OA, as well as nonspecific low back pain (NLP), it became possible to include CMMRs in the Clinical Guidelines for Polyarthrosis (Generalized Osteoarthritis), approved in late 2025 and valid through 2027. This article provides a brief overview of the key clinical studies that served as the rationale for including CMMRs in the clinical guidelines, as well as key materials on a recently registered Russian drug from the CMMR group. A literature search was conducted in eLibrary.ru for the period from 2020 to 2025. The search string included “CMMR” or trade names of drugs present in the abstract, article title, keywords, or full text of the publication, with the requirement that the full text of the article be available on eLibrary.ru. A total of 98 references were identified, including six duplicates in both lists. Analysis of 92 sources revealed that 39 presented clinical trial results, 13 described clinical cases, and 40 contained clinical reviews, meeting resolutions, or expert consensus statements on the use of CMMR.

  • Use of a domestic biopolymer microheterogeneous collagen-containing hydrogel for knee osteoarthritis

    by Kovalenko P.S. Kovalenko, Dydykina I.S. Dydykina, Alekseeva O.G. Alekseeva, Zelenov V.A. Zelenov, Zotkin E.G. Zotkin

  • Open Access

    Increased bone mineral density in the lumbar spine in patients with rheumatoid arthritis during long-term observation: paradox or regularity

    by P. S. Kovalenko, I. S. Dydykina, A. V. Smirnov, S. I. Glukhova, E. L. Nasonov

    Introduction. Chronic inflammation in rheumatoid arthritis (RA) is one of the causes of activation of bone resorption, occurrence of erosive changes, disruption of microarchitecture, bone mineral density (BMD) decrease and increased risk of vertebral and peripheral bone fractures. The aim – to study the dynamics of bone mineral density, vertebral deformations and degenerative changes in the lumbar spine in patients with rheumatoid arthritis during long-term prospective observation. Materials and methods. A prospective multi-year cohort study, the duration of which was 9.7±1.7 years, included 151 women with RA aged 53.9±9.2 years with a reliable diagnosis established at the age of 41.9±12.5 years. All patients underwent clinical, laboratory and radiological examination (X-ray densitometry of the lumbar spine (L1–L4), femoral neck (FN) and total hip (TH), X-ray morphometry of the spine using the Genant method, assessment of degenerative changes in the lumbar spine) in dynamics. Results. A BMD decrease in FN and TH and stabilization in L1–L4 were established; in patients over 55 years of age it was an increase in BMD in L1–L4 and a decrease in FN and TH; a decrease in BMD in all studied skeletal regions in patients under 55 years of age. The appearance or increase in deformations (fractures) of the vertebrae in the thoracic spine was observed in 50 (33%) patients, in the lumbar spine – in 4 (2.6%) patients; a relationship between deformations (fractures) of the vertebrae and an increase in BMD was not established. An increase in degenerative changes in all segments of the lumbar spine was established in patients with pain and a significant increase in L1–L4 BMD. Long-term monotherapy with DMARDs, as well as with biologics, did not have a positive effect on the BMD. Conclusions. A long-term prospective cohort study revealed stabilization of the BMD in L1–L4; its increase in the group of patients with RA over 55 years of age against the background of the appearance or intensification of the initial deformation (fractures) of the vertebrae; and an increase in degenerative changes in all segments of the lumbar spine.

  • Open Access

    Back pain in patients with rheumatoid arthritis (based on long-term prospective observation)

    by P. S. Kovalenko, I. S. Dydykina, A. V. Smirnov, S. I. Glukhova, E. L. Nasonov

    Back pain (BP) is less common in patients with rheumatoid arthritis (RA) than in the general population. However, RA patients who do experience BP tend to have lower functional activity scores, lower general health assessments, and higher overall pain intensity. The development of osteoporosis (OP) is considered a risk factor for vertebral fractures and possibly for BP. Objective : to identify factors influencing the onset and persistence of pain in the thoracic and lumbar spine in RA patients under long-term prospective observation. Material and methods . This prospective, non-interventional cohort study included 151 women with RA. The mean patient age was 53.9±9.2 years; the average age at onset of BP was 53.6±12.2 years, and at RA diagnosis – 41.9±12.5 years. The average follow-up duration was 9.7±1.7 years. All patients underwent clinical, laboratory, and radiological assessments at baseline and during follow-up, including spinal radiomorphometry according to Genant, X-ray densitometry of the lumbar spine (LI–LIV), and femoral neck. Pain was assessed using the visual analogue scale (VAS). Results and discussion . During the follow-up, the number of women with BP increased from 96 (63%) to 116 (77%), and those with lumbar pain from 77 (51%) to 101 (67%). VAS pain intensity in the thoracic spine averaged 49±18 mm at baseline and 51±16 mm at follow-up; in the lumbar spine, 47±21 mm and 51±19 mm, respectively. Pain in the thoracic spine appeared or worsened in 31 (20%) cases; in the lumbar spine, in 65 (43%). At baseline, 23 patients (62%) reported severe thoracic pain (>40 mm), and 56 (73%) reported lumbar pain; by the end of the study, these figures were 26 (60%) and 78 (77%), respectively. Conclusion . Severe thoracic BP (>40 mm) was associated with RA activity, while lumbar pain was linked to age, daily glucocorticoid dose, DAS28 index, HAQ index, and degenerative changes in LII–LIII, LIII–LIV, and LIV–LV. No significant association was found between BP and vertebral deformities, prior peripheral fractures, bone mineral density in LI–LIV or the proximal femur, or T-scores below <-2,5.

  • Open Access

    Changes in bone tissue parameters and pain index in the lumbar spine in patients with rheumatoid arthritis

    by P. S. Kovalenko, I. S. Dydykina, A. V. Smirnov, S. I. Glukhova, E. L. Nasonov

    Introduction. Changes in the qualitative and quantitative parameters of bone tissue, the structure and density of the vertebrae, and intervertebral discs affect the severity of pain in the lumbar spine (LS). Pain in the LS in RA is less common than in the population and is associated with low functional activity and higher pain rates in general.Aim. To study changes in bone tissue parameters and pain index in the pelvic floor in patients with RA during long-term prospective observation.Materials and methods. The prospective multi-year cohort study included 151 women with RA aged 53.9 ± 9.2 years, with a follow-up period of 9.7 ± 1.7 years, with recurrence of pain in the pelvic area from 53.6 ± 12.2 years, which was assessed using the VAS scale (mm). All patients underwent clinical, laboratory and radiological examination of the pelvic area at baseline and over time.Results. Δ BMD in L1-L4 was -0.75%, in the SB – -8.6%, in the total hip – -5.3%. X-ray morphometry revealed the appearance or increase of the initial deformation (fractures) of the vertebrae in the POP without an increase in BMD in L1–L4 in 4 (2.6%) people. Degenerative changes increased in all analyzed segments of the POP. The number of patients with pain in the POP increased from 77 (51%) to 101 (67%) people, the pain intensity was 47 ± 21 points, became 51 ± 19 points.Conclusions. Long-term observation revealed stabilization of BMD in L1–L4; in patients younger than 55 years, a decrease was noted, and in patients older than 55 years, an increase in BMD. A relationship was established between the increase in BMD in L1–L4 and degenerative changes in the PP. Severe pain in the PP correlated with age, daily dose of glucocorticoids, RA activity according to DAS-28, health status assessment, and degenerative changes in the dynamics of the L2–L3, L3–L4, L4–L5 segments.

  • Open Access

    Use of the AMS questionnaire to hypogonadism screening in men with rheumatoid arthritis

    by T. S. Panevin, E. G. Zotkin, I. S. Dydykina, A. S. Potapova, S. I. Glukhova, M. V. Cherkasova, M. E. Diatroptov

    Introduction. The proportion of men with rheumatoid arthritis (RA) reaches 25%. Given the previously identified high frequency of decreased testosterone in men with RA, the issue of clinical diagnosis of hypogonadism is relevant.Aim. To evaluate the effectiveness of the Aging Male Symptoms (AMS) questionnaire for diagnosing hypogonadism among patients with RA.Materials and methods. A cross-sectional continuous study included 78 men with RA who were undergoing inpatient treatment at the V.A. Nasonova Research Institute of Rheumatology. The patients underwent determination of their total testosterone levels. All men completed the AMS questionnaire to screen for clinical signs of testosterone deficiency. A correlation analysis was performed between the AMS scores with the testosterone level and clinical and laboratory parameters of RA. ROC analysis of the sensitivity and specificity of the AMS questionnaire was performed in comparison with laboratory diagnostics of hypogonadism.Results. Based on the results of the questionnaire, androgen deficiency was suspected in 70.5%. Hypogonadism (decreased testosterone levels < 12.0 nmol/l) was detected in 33.3% of patients. A significant negative correlation was found between the total score of the AMS questionnaire and all three subgroups of questions with the level of total testosterone. A moderate correlation was noted between age and the sexual symptoms of the questionnaire. The DAS28 index, the number of swollen joints and the level of C-reactive protein significantly positively correlated with the total score of the AMS, as well as with its somatic and psychological components. When conducting the ROC analysis, the area under the ROC curve was 0.728 (95% CI 0.604–0.851; p < 0.001). The threshold value for the AMS questionnaire at the cut-off point was 38.5 points. The sensitivity and specificity of the model were 75.0% and 69.2%. The diagnostic accuracy of the questionnaire was 51.3%, the positive predictive value was 39.3%, and the negative predictive value was 81.8%.Conclusion. The AMS questionnaire can be effective for diagnosing androgen deficiency symptoms in men with RA, but RA activity makes a significant contribution to the score, which increases the threshold value at which the questionnaire shows satisfactory sensitivity and specificity.


  • Review and resolution of the Council of Experts on the topic «The role of the combination of undenatured type II collagen UC-II, vitamin C, and trace elements in recovering and maintaining the function of the musculoskeletal system, and preservation of health of the joints»

    by E.V. Ekusheva, E.G. Zotkin, I.S. Dydykina, A.S. Dukhanin, O.V. Kalyuzhin, V.V. Ar’kOv, A.YU. Sidenkov, E.S. Akarachkova

    On October 6, 2024, the Council of Experts held a meeting to discuss «The role of the combination of undenatured type II collagen UC-II, vitamin C, and trace elements in recovering and maintaining the function of the musculoskeletal system and preservation of joint health.» New opportunities in preventing and treating osteoarthritis (OA), including in comorbid patients, are considered. Leading experts in rheumatology, clinical pharmacology, neurology, clinical immunology, orthopedics, traumatology, and sports medicine attended the meeting. The OA phenotypes, the mechanism of action of undenatured type II collagen, the data of clinical studies with undenatured collagen UC II, the integrative, interdisciplinary approach in the prevention and treatment of OA, and the prospects for using the VoltaFlex dietary supplement were analyzed. The resolution of the Council of Experts emphasized the importance of an integrated approach to the treatment of OA, including pharmacological and non-drug methods, and recommended using a combination of undenatured type II UC-II collagen, vitamin C, and trace elements to recover and maintain the musculoskeletal system’s function and preserve joint health.


  • Open Access

    Fractures of vertebrae and peripheral bones in patients with rheumatoid arthritis (based on long-term observation)

    by Polina S. Kovalenko, Irina S. Dydykina, Polina O. Postnikova, Svetlana I. Glukhova, Alexander V. Smirnov

    Introduction. In rheumatoid arthritis (RA), fractures occur on average 2–3 times more often than in the general population. Data on the incidence of vertebral fractures in RA is controversial and depends on the detection method. Aim. To determine the incidence of vertebral and peripheral bone fractures in patients with RA during long-term prospective follow-up. Materials and methods. A prospective multi-year cohort non-interventional study included 120 women with RA (mean age at enrollment 54.3±8.9 years), with a follow-up of 9.5±1.9 years. Initially and then repeatedly, a clinical, laboratory and radiological examination was performed: X-ray morphometry of the spine according to the Genant method, X-ray densitometry of the lumbar spine (LI-LIV) and femoral neck. Results. During the follow-up period, there were 104 low-energy fractures in 64 (53%) patients: 69 (66%) vertebral fractures and 35 (34%) peripheral fractures. Two or more fractures occurred in 25 (39%) subjects. In 30 (25%) patients, 52 fractures occurred repeatedly. Among peripheral fractures, the most frequent localization was fractures of the distal forearm and lower leg bones. Patients with fractures during the follow-up period were also more likely to have fractures before enrollment in the study, had an initially longer duration of RA, a mean daily dose, cumulative dose, and duration of glucocorticoid administration, and a lower bone mineral density in the main parts of the skeleton, determined by densitometry. There was no effect of RA activity on DAS-28, rheumatoid factor positivity, or antibodies to cyclic citrullinated peptide on fractures. Conclusion. More than half of the patients had low-energy fractures during the observation period, the most common being fractures of the vertebrae, distal forearm, and lower leg bones; a high frequency of repeated fractures was reported. The analysis of risk factors showed that a long duration of RA, a mean daily dose, cumulative dose, and prolonged use of glucocorticoids, a history of low-energy fractures, and low bone mineral density were associated with the occurrence of fractures in patients with RA.